Loading…
← CockpitCompetitor Analysis › 301228.SZ SEP Analytical (Shanghai) Co., Ltd. Class AOpen in the cockpit ↗

SEP Analytical (Shanghai) Co., Ltd. Class A301228.SZCompetitor analysis, valuation and peers

China · CNY·Industrials›Miscellaneous Commercial Services

Chinese maker of analytical instruments, likely lab testing or measurement equipment.

Momentum laggard 4
Mkt cap
$663M
US dollars, full cap
$/day
$13.9M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-7.0 pp
WACC 6.0%
Hurdle
n/a
no reverse DCF
Close · CNYCN¥35.80
1D-0.7%
1W-16.0%
1M-22.2%
3M-44.8%
6M-41.8%
YTD-7.3%
1Y+33.6%
ATR %8.2%
52w lowhigh57.9% off high

What SEP Analytical (Shanghai) does

Chinese maker of analytical instruments, likely lab testing or measurement equipment.

Where it sits in the supply chain

  • Instruments
  • Analytical instruments

Moat: none

Headquarters: Shanghai, China · Employees: 1,032

SEP Analytical (Shanghai) at a glance

Size SEP Analytical (Shanghai) (301228.SZ) is a China Industrials company (Miscellaneous Commercial Services) with a market value of $663M, the 3017th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥35.80 on 18 Nov 2026.

Performance Over six months the shares fell 41.8%, against -22.5% for the median peer and -20.0% for the China market (cap-weighted) — 6th lowest of 21 in its peer set.

Growth Revenue grew 5.1% over the last twelve months (peer median +11.6%); the operating margin is -9.0% (peer median 5.6%).

Valuation It trades at 10.8× enterprise value to sales against a peer median of 2.9× (3rd most expensive of 21).

Capital Return on invested capital runs 7.0 points below its cost of capital (6.0% WACC).

Relative performance

7510012521 May 202621 Aug 202618 Nov 2026Peer median 77301228.SZ 57
Six months, rebased to 100: SEP Analytical (Shanghai) against the median of its 20 peers (local-currency closes).

SEP Analytical (Shanghai) financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥407MCN¥397MCN¥441MCN¥373MCN¥351M
Revenue growth—-10%+18%+6%—
Gross profitCN¥121MCN¥69.1MCN¥109MCN¥60.5MCN¥104M
EBITDAn/aCN¥2.59M-CN¥239,040-CN¥34.2MCN¥28.8M
Net income-CN¥57.2M-CN¥68.0M-CN¥65.8M-CN¥93.5M-CN¥18.0M
Free cash flow-CN¥137M-CN¥14.5MCN¥12.6M-CN¥49.0M-CN¥39.2M
Capital expenditureCN¥118MCN¥58.7MCN¥16.1MCN¥40.7MCN¥52.6M
Total debtCN¥179MCN¥122MCN¥76.3MCN¥75.9MCN¥71.3M

Quarterly statements and history in the cockpit →

SEP Analytical (Shanghai) competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-60%-40%-20%0%-20%-10%0%2874RWS300492JSGGUBRA688170CGY3015086887073007970029156183WLNFRAMERYAUB688150301230688480688360301306301228.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. SEP Analytical (Shanghai) is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%0×5×10×2874RWS300492JSGGUBRA688170CGY301508688707300797002915WLNFRAMERYAUB688150301230688480301306301228.SZRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. SEP Analytical (Shanghai) is the large dot.

SEP Analytical (Shanghai) competitors and peer comparison

How SEP Analytical (Shanghai) compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

SEP Analytical (Shanghai) against its 20 peers (data as of 18 Nov 2026)
Measure301228.SZPeer medianRank in peer set
1-month return-22.2%-11.2%2nd lowest of 21
6-month return-41.8%-22.5%6th lowest of 21
Distance from 52-week high-57.9%-45.2%5th lowest of 21
Revenue growth (TTM)+5.1%+11.6%8th lowest of 21
Operating margin-9.0%5.6%4th lowest of 21
EV / Sales10.8×2.9×3rd most expensive of 21
ROIC minus cost of capital-7.0 pp-1.8 pp5th lowest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
SEP Analytical (Shanghai) 301228.SZChina$663M-42%+5%-9%10.8×n/an/a
Yokorei 2874.TJapan$663M-9%+4%5%1.5×n/an/a
RWS RWS.LUnited Kingdom$669M+41%-1%4%0.8×11.9%+14.2%
Huatu Cendes 300492.SZChina$671M-50%-8%-2%1.4×13.9%+91.2%
Johnson Service JSG.LUnited Kingdom$674M+7%+2%11%1.3×8.2%+18.4%
Gubra A/S GUBRA.CODenmark$651M-21%-90%-72%13.7×n/an/a
Suzhou Delphi Laser 688170.SSChina$649M-42%+20%1%4.6×n/an/a
Calian CGY.TOCanada$677M+2%+16%6%1.3×13.7%+12.4%
China Machinery Huanyu Certification & Inspection 301508.SZChina$681M-24%+10%21%4.2×5.5%+15.4%
Guizhou Zhenhua E-Chem 688707.SSChina$681M-44%+15%-17%2.9×1.9%+6.6%
NCS Testing Technology 300797.SZChina$644M-27%+15%7%3.2×21.4%+15.0%
Zhejiang Zhongxin Fluoride Materials 002915.SZChina$683M-41%+8%2%3.5×n/an/a
BELLSYSTEM24 6183.TJapan$642M-3%+1%8%1.0×-5.7%+1.4%
Worldline WLN.PAFrance$642M-28%-18%2%0.7×16.9%+10.4%
Framery FRAMERY.HEFinland$640M0%+37%22%2.9×5.5%+13.4%
Aubay AUB.PAFrance$690M-7%+27%9%0.9×2.6%+7.1%
Shaanxi Lighte Optoelectronics Material 688150.SSChina$692M-56%+14%39%6.7×n/an/a
PharmaResources (Shanghai) 301230.SZChina$695M-10%+9%0%6.2×39.0%+19.5%
Science Environmental Protection 688480.SSChina$632M-56%+37%10%3.0×26.2%+28.2%
Damon Technology 688360.SSChina$627M-19%+19%7%2.5×8.8%+17.1%
Xi'an Xice Testing Technology 301306.SZChina$625M-58%+21%-27%13.1×n/an/a

Questions

Which companies are SEP Analytical (Shanghai)'s closest peers?
The cockpit's peer set: Yokorei (2874.T), RWS (RWS.L), Huatu Cendes (300492.SZ), Johnson Service (JSG.L), Gubra A/S (GUBRA.CO), Suzhou Delphi Laser (688170.SS), Calian (CGY.TO), China Machinery Huanyu Certification & Inspection (301508.SZ).
Is SEP Analytical (Shanghai) expensive compared with its peers?
On ev / sales it trades at 10.8× against a peer median of 2.9×, 3rd most expensive of 21 in its peer set.
How has SEP Analytical (Shanghai) stock performed?
Over six months to 18 Nov 2026 the shares returned -41.8% against -22.5% for the median peer; over one year +33.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.